Arnon Rosenthal
Vermogen: 14 M $ op 31-05-2026
Vermogen: 14 M $ op 31-05-2026
Arnon Rosenthal was the founder of Annexon, Inc. (founded in 2011, titled: Chairman from 2014 to 2017), Rinat Neuroscience Corp.
(founded in 2001, titled: President, Director & Chief Scientific Officer from 2001 to 2006), and Alector, Inc. (founded in 2013, titled: Chief Executive Officer & Director since 2019).
Former job at Genentech, Inc. as Scientist from 1985 to 2001.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALECTOR, INC. 5,67% | 02-06-2026 | 6.297.581 ( 5,67% ) | 14 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ALECTOR, INC. | Oprichter | 01-05-2013 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ANNEXON, INC. | Algemeen Directeur | 01-12-2014 |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Oprichter | 01-08-2006 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-08-2001 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau